How Near-Infrared Light Affects Brain Function

Near-infrared wavelengths (800–900nm) penetrate the skull and reach cortical tissue to depths of 2–3 centimeters. In brain tissue, the same mitochondrial mechanism that drives red light therapy's other benefits applies: cytochrome c oxidase absorbs photons, restoring electron transport chain efficiency and increasing ATP production in neurons. Brain cells are among the most energy-hungry cells in the body—neurons depend on continuous high ATP production for synaptic function, neurotransmitter synthesis, and the maintenance of neuronal architecture. In depression and anxiety disorders, evidence suggests compromised mitochondrial function and reduced cerebral energy metabolism in specific brain regions. Restoring cellular energy capacity in these regions through transcranial photobiomodulation addresses a fundamental biological aspect of these conditions.

Clinical Evidence for Transcranial Photobiomodulation in Depression

A pioneering study by Cassano et al. at Harvard Medical School found significant reductions in depression scores (Hamilton Rating Scale for Depression) in treatment-resistant major depressive disorder patients receiving transcranial near-infrared light therapy. Several subsequent studies have shown similar results, with response rates comparable to antidepressant medications in pilot trials. A 2020 randomized controlled trial found significant improvements in mood, anxiety, and cognitive function in patients receiving transcranial PBM compared to sham. While the evidence base is smaller than for pharmaceutical treatments (reflecting the recency of this research rather than lack of efficacy), the consistent direction of findings across independent research groups is encouraging.

Serotonin, Dopamine, and the Neurochemistry of Mood

Red light therapy's potential mood benefits may extend beyond direct mitochondrial effects to include modulation of neurotransmitter systems. Research suggests that photobiomodulation increases serotonin levels in the prefrontal cortex—a region centrally involved in mood regulation and commonly dysregulated in depression. The mechanism may involve increased tryptophan hydroxylase activity (the rate-limiting enzyme in serotonin synthesis) driven by improved cellular energy availability. Dopamine pathway effects have also been proposed, with implications for motivation, reward processing, and anhedonia—the inability to experience pleasure that is one of depression's most debilitating symptoms.

Practical Application: Transcranial Photobiomodulation at Home

Applying near-infrared light transcranially at home requires specific considerations. The forehead and temporal regions are the most common targets, providing access to the prefrontal cortex and surrounding regions implicated in mood and emotion regulation. Irradiance must be sufficient to achieve therapeutic doses through the skull—typically requiring devices with irradiance of 100+ mW/cm² at skin contact, as skull bone attenuates approximately 50–80% of incident light before it reaches cortical tissue. Session duration of 10–20 minutes, 3–5 times weekly, is the most commonly used protocol in clinical studies. Standard consumer red light therapy panels can be used for transcranial application by positioning the forehead and temples toward the device at close distance.

Red Light Therapy as Part of a Mental Health Support Protocol

For individuals experiencing depression or anxiety, red light therapy should be understood as a potential complementary support tool—not a replacement for evidence-based psychological treatments (CBT, DBT, psychotherapy) or appropriate pharmacological treatment when indicated. Red light therapy's sleep optimization effects address one of the most significant contributors to mood disorders. Its anti-inflammatory effects address the chronic low-grade inflammation increasingly recognized as a driver of treatment-resistant depression. Its direct transcranial effects may address neurobiological aspects of depression at the cellular level. Together, these mechanisms make it a genuinely reasonable addition to a comprehensive mental health support approach, particularly for individuals who cannot tolerate conventional antidepressants or wish to minimize pharmaceutical dependence.

Medical Disclaimer: This article is for educational purposes only and is not intended as medical advice. Red light therapy devices are not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any new health protocol, particularly if you have a medical condition or take medications.

Bottom Line

Transcranial photobiomodulation for depression and mood disorders has a growing evidence base suggesting genuine neurobiological effects on brain energy metabolism, neurotransmitter systems, and mood outcomes. While the research is earlier stage than red light therapy's physical health applications, the consistent positive findings across multiple independent research groups position it as a promising and low-risk complementary approach to mental health support.

Ready to Experience Red Light Therapy?

Explore near-infrared devices with sufficient output for effective transcranial photobiomodulation.